Bin Li

8PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2026
Integrative transcriptomic and experimental analysis identifies GREM1 as a pro-metastatic mediator in lung adenocarcinoma.

|Jul 08, 2026
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

|Feb 04, 2026
Caveolin-1 drives immunosuppression in esophageal squamous cell carcinoma by enhancing exosome secretion and macrophage M2 polarization via inhibition of MVB autophagic degradation.

Ke-Rong Zhai, Pei-Lin Zhao, Zi-Han Wang

|Jan 21, 2026
Exploring the genetic link between type 2 diabetes and its complications and esophageal malignancy: A Mendelian randomization study.

Mingzhi Lin, Chongrui Li, Bin Li

|Jul 21, 2025
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Chong-Rui Li, Ming-Zhi Lin, Bin Li

|Jul 17, 2025
Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis.

Chong-Rui Li, Yu-Zhen Chen, Bin Li

Pageof 2

Frequent Collaborators

1 joint publications

Qiyao Yu

1 joint publications

Junfeng Liu